marginally significantP =0.034
There was a marginally significant 8.1% reduction in CVD risk with a 10% increase in F 2 IP ( P =0.034) without adjustment for HbA1c that became nonsignificant after such adjustment ( P =0.057).
There was a marginally significant 8.1% reduction in CVD risk with a 10% increase in F 2 IP ( P =0.034) without adjustment for HbA1c that became nonsignificant after such adjustment ( P =0.057).
Similar effects were observed without the HbA1c adjustment, as well as a nominally significant reduction by 4.8% in the intensive group ( P =0.046).